Skip to main content
Top
Published in: BMC Infectious Diseases 1/2019

Open Access 01-12-2019 | Hepatitis B | Research article

Sero-prevalence of hepatitis B virus and associated factors among pregnant women in Gambella hospital, South Western Ethiopia: facility based cross-sectional study

Authors: Abayneh Tunje Tanga, Misanew Andargie Teshome, Desta Hiko, Chaltu Fikru, Gemechu Kejela Jilo

Published in: BMC Infectious Diseases | Issue 1/2019

Login to get access

Abstract

Background

Hepatitis B virus (HBV) is a hepatotropic deoxyribonucleic acid (DNA) virus which causes death. More than 300 million people have chronic liver infections globally and about 600,000 people die annually from acute or chronic complications of hepatitis B infection. Recent studies conducted in Ethiopia showed moderate endemicity (3–7.8%) of HBV among pregnant women. However, there is paucity of information on sero- prevalence of HBV and associated factors among pregnant women at Gambella town. The aim of this study is to assess sero-prevalence of hepatitis surface antigen (HBsAg) and associated factors among pregnant women in Gambella Hospital.

Methods

Hospital based cross-sectional study was conducted in a total of 253 pregnant women from March 10–April 15, 2017. Socio-demographic characteristics and risk factors were collected through face to face interview using structured questionnaire. HBV infection was determined using Eugene strip test. Logistic regression analysis was used to determine association between HBsAg sero-positivity and various factors. Findings were presented using 95% CI of Crude Odds Ratios (COR) and Adjusted Odds Ratios (AOR).

Result

The overall sero- prevalence of HBV infection was 7.9% (95% CI, 4.7–11.9), which indicates intermediate endemicity. History of abortion (AOR = 3.56:1: 95% CI, 1.24–10.22), occupation (AOR = 8.36:95% CI, 1.67–41.96) and multiple sexual partner (AOR = 17.38: 95% CI, 4.48–67.49) had statistical significant association with HBsAg sero-positivity.

Conclusion

HBV sero-prevalence in pregnant women shows intermediate endemicity. Hence health education on having single sexual partner and risk factors of abortion should be given. In addition, routine screening and immunization of pregnant women for HBV infection should be strengthen.
Literature
2.
go back to reference WHO, UNICEF, World Bank. State of the world’s vaccines and immunization, 3rd ed. Geneva: World Health Organization; 2009. WHO, UNICEF, World Bank. State of the world’s vaccines and immunization, 3rd ed. Geneva: World Health Organization; 2009.
3.
go back to reference Bosse T. Infectious Disease Epidemiology Report; 2015. Bosse T. Infectious Disease Epidemiology Report; 2015.
4.
go back to reference Mauss, Berg, Rockstroh, Sarrazin, Wedemeyer. Hepatology a clinical textbook. 7th ed. Koblenz: Druckerei Heinrich GmbH; 2016. Mauss, Berg, Rockstroh, Sarrazin, Wedemeyer. Hepatology a clinical textbook. 7th ed. Koblenz: Druckerei Heinrich GmbH; 2016.
7.
go back to reference Kolawole OM, Wahab AA, Adekanle DA, Sibanda T, Okoh A. Sero-prevalence of hepatitis B surface antigenemia and its effects on hematological parameters in pregnant women in Osogbo, Nigeria. Virol J. 2012;9:317.CrossRef Kolawole OM, Wahab AA, Adekanle DA, Sibanda T, Okoh A. Sero-prevalence of hepatitis B surface antigenemia and its effects on hematological parameters in pregnant women in Osogbo, Nigeria. Virol J. 2012;9:317.CrossRef
8.
go back to reference Tegegne D, Desta K, Tegbaru B, Tilahun T. Seroprevalence and transmission of Hepatitis B virus among delivering women and their new born in selected health facilities, Addis Ababa,Ethiopia: a cross sectional study. BMC Res Notes. 2014;7:239.CrossRef Tegegne D, Desta K, Tegbaru B, Tilahun T. Seroprevalence and transmission of Hepatitis B virus among delivering women and their new born in selected health facilities, Addis Ababa,Ethiopia: a cross sectional study. BMC Res Notes. 2014;7:239.CrossRef
9.
go back to reference Metaferia Y, Dessie W, Ali I, Amsalu A. Seroprevalence and associated risk factors of hepatitis B virus among pregnant women in southern Ethiopia: a hospital-based cross-sectional study. Epidemiol Health. 2016;38:2016027.CrossRef Metaferia Y, Dessie W, Ali I, Amsalu A. Seroprevalence and associated risk factors of hepatitis B virus among pregnant women in southern Ethiopia: a hospital-based cross-sectional study. Epidemiol Health. 2016;38:2016027.CrossRef
10.
go back to reference Seid M, Gelaw B, Assefa A. Sero-prevalence of HBV and HCV infections among pregnant women attending antenatal Care Clinic at Dessie Referral Hospital, Ethiopia. Adv Life Sci Health. 2014;1(2):109–20. Seid M, Gelaw B, Assefa A. Sero-prevalence of HBV and HCV infections among pregnant women attending antenatal Care Clinic at Dessie Referral Hospital, Ethiopia. Adv Life Sci Health. 2014;1(2):109–20.
12.
go back to reference Yohanes T, Zerdo Z, Chufamo N. Seroprevalence and predictors of Hepatitis B virus infection among pregnant women attending routine antenatal Care in Arba Minch Hospital, South Ethiopia. Hepat Res Treat. 2016;2016(2):1–7.CrossRef Yohanes T, Zerdo Z, Chufamo N. Seroprevalence and predictors of Hepatitis B virus infection among pregnant women attending routine antenatal Care in Arba Minch Hospital, South Ethiopia. Hepat Res Treat. 2016;2016(2):1–7.CrossRef
13.
go back to reference Zenebe, et al. Sero-prevalence and risk factors of hepatitis B virus and human immunodeficiency virus infection among pregnant women in Bahir Dar city, Northwest Ethiopia: a cross sectional study. BMC Infect Dis. 2014;14:118.CrossRef Zenebe, et al. Sero-prevalence and risk factors of hepatitis B virus and human immunodeficiency virus infection among pregnant women in Bahir Dar city, Northwest Ethiopia: a cross sectional study. BMC Infect Dis. 2014;14:118.CrossRef
14.
go back to reference Tse KY, Ho LF, Lao T. The impact of maternal HBsAg carrier status on pregnancy outcomes:case–control study. J Hepatol. 2005;43 Epub 775.CrossRef Tse KY, Ho LF, Lao T. The impact of maternal HBsAg carrier status on pregnancy outcomes:case–control study. J Hepatol. 2005;43 Epub 775.CrossRef
15.
go back to reference Zhang S, Zhou Y. The analysis and application of an HBV model. Appl Math Model. 2012;36:1302–12.CrossRef Zhang S, Zhou Y. The analysis and application of an HBV model. Appl Math Model. 2012;36:1302–12.CrossRef
16.
go back to reference Afzali H, Heravi MM, Moravveji SA, Poorrahnama M. Prevalence of Hepatitis B surface antigen in pregnant women in Beheshti Hospital of Kashan, Isfahan. Iran Red Crescent Med J. 2015;17(7):e20598.CrossRef Afzali H, Heravi MM, Moravveji SA, Poorrahnama M. Prevalence of Hepatitis B surface antigen in pregnant women in Beheshti Hospital of Kashan, Isfahan. Iran Red Crescent Med J. 2015;17(7):e20598.CrossRef
18.
go back to reference WHO. Introduction of hepatitis B vaccine into childhood immunization services. 2001. WHO. Introduction of hepatitis B vaccine into childhood immunization services. 2001.
19.
go back to reference MacLean B, Hess RF, Bonvillain E, Kamate J, Dao D, Cosimano A, et al. Seroprevalence of hepatitis B surface antigen among pregnant women attending the Hospital for Women & children in Koutiala, Mali. SAMJ. 2012;102(1):47–9. MacLean B, Hess RF, Bonvillain E, Kamate J, Dao D, Cosimano A, et al. Seroprevalence of hepatitis B surface antigen among pregnant women attending the Hospital for Women & children in Koutiala, Mali. SAMJ. 2012;102(1):47–9.
20.
go back to reference Angounda BM, Dzia AB, Boumba LMA, Clotaire I, Ahombo G, et al. Prevalence of serologic markers and risk factors for Hepatitis B virus among pregnant women in Brazzaville, Congo. Int J Sci Res. 2016;5(1):1907–12. Angounda BM, Dzia AB, Boumba LMA, Clotaire I, Ahombo G, et al. Prevalence of serologic markers and risk factors for Hepatitis B virus among pregnant women in Brazzaville, Congo. Int J Sci Res. 2016;5(1):1907–12.
21.
go back to reference Noubiap JJN, Nansseu JRN, Ndoula ST, Bigna JJR, Jingi AM, Fokom-Domgue J. Prevalence, infectivity and correlates of hepatitis B virus infection among pregnant women in a rural district of the far north region of Cameroon. BMC Public Health. 2015;15:454.CrossRef Noubiap JJN, Nansseu JRN, Ndoula ST, Bigna JJR, Jingi AM, Fokom-Domgue J. Prevalence, infectivity and correlates of hepatitis B virus infection among pregnant women in a rural district of the far north region of Cameroon. BMC Public Health. 2015;15:454.CrossRef
22.
go back to reference Nyamusi MM, Marete OT, Waweru WR. Seroprevalence of hepatitis B among pregnant women in Kigali, Rwanda. Int J Community Med Public Health. 2016;3(11):3096–101.CrossRef Nyamusi MM, Marete OT, Waweru WR. Seroprevalence of hepatitis B among pregnant women in Kigali, Rwanda. Int J Community Med Public Health. 2016;3(11):3096–101.CrossRef
23.
go back to reference Alegbeleye JO, Nyengidiki TK, Ikimalo JI. Maternal and neonatal seroprevalence of hepatitis B surface antigen in a hospital based population in south-south, Nigeria. Int J Med Med Sci. 2013;5(5):241–6. Alegbeleye JO, Nyengidiki TK, Ikimalo JI. Maternal and neonatal seroprevalence of hepatitis B surface antigen in a hospital based population in south-south, Nigeria. Int J Med Med Sci. 2013;5(5):241–6.
24.
go back to reference Walle F, Asrat D, Alem A, Tadesse E, Desta K. Prevalence of hepatitis b surface antigen among pregnant women attending antenatal care service at Debre-Tabor hospital, Northwest Ethiopia. Ethiop J Health Sci. 2008;17(1):13–21. Walle F, Asrat D, Alem A, Tadesse E, Desta K. Prevalence of hepatitis b surface antigen among pregnant women attending antenatal care service at Debre-Tabor hospital, Northwest Ethiopia. Ethiop J Health Sci. 2008;17(1):13–21.
25.
go back to reference Medhin ANZS. Prevalence of Hepatitis B surface antigen (HBsAg) among visitors of Shashemene general hospital voluntary counseling and testing center. BMC Res Notes. 2011;4:35.CrossRef Medhin ANZS. Prevalence of Hepatitis B surface antigen (HBsAg) among visitors of Shashemene general hospital voluntary counseling and testing center. BMC Res Notes. 2011;4:35.CrossRef
Metadata
Title
Sero-prevalence of hepatitis B virus and associated factors among pregnant women in Gambella hospital, South Western Ethiopia: facility based cross-sectional study
Authors
Abayneh Tunje Tanga
Misanew Andargie Teshome
Desta Hiko
Chaltu Fikru
Gemechu Kejela Jilo
Publication date
01-12-2019
Publisher
BioMed Central
Keyword
Hepatitis B
Published in
BMC Infectious Diseases / Issue 1/2019
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-019-4220-z

Other articles of this Issue 1/2019

BMC Infectious Diseases 1/2019 Go to the issue